跳至主要内容
临床试验/JPRN-UMIN000012340
JPRN-UMIN000012340已完成未知

Examnitaion of the primary prevention effect of BPSD in the additional dosage of the mementine hydrochloride for the Alzheimer's disease - the study of the additional dosage of the mementine hydrochloride

Osaka City University Graduate school of Medicine0 个研究点目标入组 80 人开始时间: 2013年11月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.dementia patients except Alzheimer's desease 2.the patients who have severe mental desorder 3.the patients having the serious disease including the malignant neoplasm 4.the patients with a history of the hypersensitivity for memantine hydrochloride 5.the patients who corresponds to a contraindication in an attached document 6.In addition, the case that a principal investigator or subinvestigator judged to be inappropriate

研究者

发起方
Osaka City University Graduate school of Medicine

相似试验